Home Page ::: Current Pharmaceutical Biotechnology

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)


Volume 16, 12 Issues, 2015


Download PDF Flyer




Current Pharmaceutical Biotechnology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 112th of 254 in

    Pharmacology & Pharmacy


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Zeno Foldes-Papp


Visiting Professor of Medical Biochemistry
HELIOS Clinical Center of Emergency Medicine
Department for Internal Medicine
Alte-Koelner-Strasse 9
D-51688 Koeln-Wipperfuerth
Germany


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.511
5 - Year: 2.817

Endorsement(s)

"Current Pharmaceutical Biotechnology presents the latest developments in the area of biotechnology. This is strongly recommended."

Robert Huber
Nobel Laureate

Forthcoming Special Issue(s)

Miniaturized platforms & methods for pharmaceutical studies


Guest Editor(s): XiuJun James Li
Tentative Publication Date: October, 2015
Submit Abstract via Email Download Description
Published Special Issue(s)

Antimicrobial Strategies Based on Natural Products: Recent Progress in Bio and Nanotechnology


Guest Editor(s): Alina Maria HOLBAN, Alexandru Mihai GRUMEZESCU
Download Description
Authors' Comments
Recently, I had a nice experience through the publication of a paper in the Current Pharmaceutical Biotechnology. I would like to take this opportunity to acknowledge the Editor in-chief of the Current pharmaceutical Biotechnology, and especially Publication Manager Ms. Sumaiya Azhar for her outstanding professionalism, kindness and availability in the management of the peer review process and the editing the manuscript. I really appreciate this nice moment.

Dr. Jin Bo Su
Has contributed: Kinins and Cardiovascular Diseases

Current Pharmaceutical Biotechnology

,

Volume 16

-

Number 7



Drug Delivery Technologies and Stem Cells for Tissue Repair and Regeneration

; Pp: 646 - 654

Gorka Orive, Raquel Cobos, Janire Gorriti, Jose L. Pedraz, Mirella Meregalli and Yvan Torrente


DOI: 10.2174/138920101607150427112457
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Antiviral activity of Trichilia catigua bark extracts for herpesvirus and poliovirus


Samantha Fernandes Espada, Ligia Carla Faccin-Galhardi, Vinicius Pires Rincao, Ana Leticia Scaldelai Bernardi, Nayara Lopes, Renata Longhini, Joao Carlos Palazzo de Mello, Rosa Elisa Carvalho Linhares and Carlos Nozawa


View Abstract

  
  


Preventing the Spread of Alzheimer’s Disease Neuropathology: A Role for Calcilytics?


Anna CHIARINI, Emanuela GARDENAL, James F. WHITFIELD, Balu CHAKRAVARTHY, Ubaldo ARMATO and Ilaria DAL PRA


View Abstract

  
  


Nasal vaccines against hepatitis B: an update


Mariana S. Almeida and Olga Borges


View Abstract

  
  


Quercetin Potently Reduces Biofilm Formation of the Strain Pseudomonas aeruginosa PAO1 in vitro


Boris Pejin, Ana Ciric, Jasmina Dimitric Markovic, Jasmina Glamoclija, Milos Nikolic, Bojana Stanimirovic and Marina Sokovic


View Abstract

  
  


Mango Polyphenols and Its Protective Effects on Diseases Associated to Oxidative Stress


Alberto J. Núñez Sellés, Diana G. Villa and Luca Rastrelli


View Abstract

  
  


Lipid Nanoparticles for the Delivery of Biopharmaceuticals


A. C. Silva, M. H. Amaral, J. M. Sousa Lobo and C. M. Lopes


View Abstract

  
  


Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:

Confocal Fluctuation Spectroscopy and Imaging

, 2010; 11(6): 639 - 653

Zeno Foldes-Papp, Shih-Chu Jeff Liao, Tiefeng You, Ewald Terpetschnig and Beniamino Barbieri


DOI: 10.2174/138920110792246618
View Abstract Download Free Rights and Permissions

  
  


AFM Studies of λ Repressor Oligomers Securing DNA Loops

, 2009; 10(5): 494 - 501

Haowei Wang, Laura Finzi, Dale E. A. Lewis and David Dunlap


DOI: 10.2174/138920109788922155
View Abstract Download Free Rights and Permissions

  
  


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science